David Brown

Biography

 David has over 30 years' experience in the pharmaceutical industry both in research and in senior executive roles. He served with four of the top ten pharmaceutical companies: Zeneca, Pfizer, Glaxo, and most recently with F. Hoffman La-Roche as Global Head of Drug Discovery, Roche Pharma. In this role he had responsibility for the output of clinical candidate drugs from approximately 200 scientists across Roche's five research sites. David has extensive experience of pharmaceutical R&D in all phases from early discovery through clinical trials, and he has experience of leading research in all major disease areas. While at Pfizer he was named co-inventor of the patent for Viagra, and he led the team that developed Viagra through to proof of concept (clinical efficacy) in man. At Roche, David also served on the committee responsible for clinical drug development and he was core member of the Business Development Committee responsible for in-licensing products and for technology agreements and acquisitions. He has also been President and CEO of biotechnology company Cellzome AG. He is now Chairman of Babraham Biotechnology, Chairman of Amura Ltd, and he serves also as a consultant to the pharmaceutical and biotechnology industry. David received his PhD in chemistry from the University of Bristol. He is an Editor-in-Chief of Current Opinion in Drug Discovery and Development, and is author of more than 50 primary and review publications and patents.

Research Interest

 Chemistry